Specificity of haemostasis abnormalities for vascular phenotypes

Haemostasis

Volumn 28, Issue 3-4, 1998, Pages 223-227

  Lowe, Gordon D O ^a   Haverkate, Frits ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b TNO   (Netherlands)

Author keywords

Cerebrovascular disease; Coronary artery disease; Coronary heart disease; Dementia; Haemostasis; Peripheral vascular disease

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VON WILLEBRAND FACTOR;

ARTICLE; CORONARY ARTERY DISEASE; DEMENTIA; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0032469657     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022434     Document Type: Article

References (37)

1. Lowe GDO: Haemostatic risk factors for arterial and venous thrombosis; in Poller L, Ludlam CA (eds): Recent Advances in Blood Coagulation, 7. Edinburgh, Churchill Livingstone, 1997, pp 69-96.
2. Pearson TA, LaCara J, Weil HFC: Epidemiology of thrombotic-haemostatic factors and their associations with cardiovascular disease. Am J Clin Nutr 1997;65(suppl):1764s-1782s.
3. Ridker PM: Fibrinolytic and inflammatory markers for arterial occlusion: The evolving epidemiology of thrombosis and hemostasis. Thromb Haemost 1997;78:53-59.
4. Meade TW, Miller GJ, Rosenberg RD: Characteristics associated with the risk of arterial thrombosis; in Verstraete M, Fuster V, Topol EJ (eds): Cardiovascular Thrombosis, Philadelphia, Lippinott-Raven, 1998.
5. Macfarlane RG: Introduction. Br Med Bull 1977;33:183-185.
6. Verstraete M, Fuster V, Topol EJ (eds): Cardiovascular Thrombosis. Philadelphia, Lippincott-Raven, 1998.
7. Mitchell JRA, Schwartz CJ: Arterial Disease. Oxford, Blackwell Scientific, 1965.
8. Gordon T, Kannel WB: Predisposition to atherosclerosis in the head, heart and legs. The Framingham Study. JAMA 1992;221:661-664.
9. Fowkes FGR (ed): Epidemiology of Peripheral Vascular Disease. London, Springer, 1991.
10. Koenig W, Hambach V, Bond MG, Kramsch DM (eds): Progression and Regression of Atherosclerosis. Vienna, Blackwell, 1995.
11. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E: Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915-1920.
12. Lee AJ, Mowbray PI, Lowe GDO, Rumley A, Fowkes FGR, Allan PL: Blood viscosity and elevated carotid intima-media thickness in men and women: The Edinburgh Artery Study. Circulation 1998;97:1467-1473.
13. Ebrahim S, Papacosta O, Whincup P, Wannamethee G, Walker M, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, Lowe GD: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: The British Regional Heart Study. Stroke 1999;30:841-850.
14. Antiplatelet Trialists Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. BMJ 1994;308:81-106.
15. CAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
16. Bucher HC, Griffith LE, Guyatt GH: Effects of HMG CoA reductase inhibitors on stroke: a meta-analysis of randomized controlled trials. Ann Intern Med 1998;128:89-95.
17. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-838.
18. Breteler MM, Clauss JJ, Grobbee DE, Hofmann A: Cardiovascular disease and distribution of cognitive function in the elderly. The Rotterdam Study. BMJ 1994;308:1604-1608.
19. Folsom AR, Wu KK, Davis CE, Conlan MB, Sorbie PO, Szklo M: Population correlates of plasma fibrinogen and factor VII, putative cardio-vascular risk factors. Atherosclerosis 1991;91:191-205.
20. Jespersen J, Bertina RM, Haverkate F (eds): Laboratory Techniques in Thrombosis: A Manual, 2nd revised edition of ECAT Assay Procedures. Dordrecht, Kluwer, 1999.
21. Thompson SG, Kiernast J, Pyke SDM, Haverkate F, van de Loo J: Haemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641.
22. Lowe GDO, Haverkate F, Thompson SG, et al: Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: The ECAT DVT Study, in press.
23. Danesh J, Collins R, Appleby P, Peto R: Association of fibrinogen, C-reactive protein, albumin, leucocyte count with coronary heart disease. JAMA 1998;279:1977-1982.
24. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963.
25. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FGR: Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. Br J Haematol 1997;96:168-173.
26. Bainton D, Sweetnam P, Baker I, Elwood P: Peripheral vascular disease. Consequence for survival and association with risk factors in the Speedwell Prospective Heart Disease Study. Br Heart J 1994;72:128-132.
27. Woodbum KR, Rumley A, Lowe GDO, Love JG, Murray GD, Pollock JG: Clinical, biochemical and rheologic factors affecting the outcome of infrainguinal bypass grafting. J Vasc Surg 1996;24:639-646.
28. Smith FB, Lowe GDO, Fowkes FGR, et al: Smoking, haemostatic factors and lipid peroxides in a population case-control study of peripheral arterial disease. Atherosclerosis 1993;102:155-162.
29. Lowe GDO: Fibrinogen - A cardiovascular risk factor. Mannheim, Boehringer Mannheim, 1997.
30. Behar S for the BIP Study Group: Lowering fibrinogen levels: Clinical update. Blood Coagul Fibrinolysis 1999;10(suppl 1):541-544.
31. Caen JP, Dronet L, Mantalescot G (eds): Fourth International Fibrinogen Symposium. Blood Coagul Fibrinolysis 1999;10(suppl 1):S1-S121.
32. Parnetti L Mari D, Abate G, et al: Vascular Dementia Italian Sulodexide Study (VADISS). Clinical and biological results. Thromb Res 1997;87:225-233.
33. Medical Research Council's General Practice Research Framework: Thrombosis Prevention Trial. Lancet 1998;351:233-241.
34. Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA, Morrison CE: Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 1997;97:785-797.
35. Lee AJ, Fowkes FGR, Lowe GDO, Rumley A: Determinants of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1995;15:1094-1097.
36. van der Bom JG: Haemostasis and cardiovascular disease; thesis, Erasmus University Medical School, Rotterdam, 1997.
37. Bots ML, Breteler MMB, van Kooten F, et al: Coagulation and fibrinolysis markers and risk of dementia. Haemostasis 1998;28:216-222.